May 12, 2021
2 min watch
Save
VIDEO: Weng discusses impact of Protocol W on NPDR treatment
Issue: June 25, 2021
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAILEA, Hawaii — In this video from Retina 2021, Christina Y. Weng, MD, MBA, discusses the impact of the recent DRCR Retina Network Protocol W, looking at the treatment of moderate to severe nonproliferative diabetic retinopathy with aflibercept.
Published by:
Sources/Disclosures
Collapse
Source:
Christina Y. Weng, MD, MBA
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.